12th World Congress News Center
12th World Congress:"Neuromodulation: Medicine Evolving Through Technology"
News Releases:
- U.S. Space Program Researchers Develop Potential Nano-Tools for Deep Brain Stimulation (embargoed for June 8, 2015)
- Weekly Non-invasive Brain Stimulation Provides Long-Term Relief of Post-Stroke Pain
(embargoed for June 8, 2015)
- More Than 1,300 International Experts in Montreal Will Address a Promising Therapeutic Avenue: Neuromodulation
- Non-Invasive Acupoint Stimulation May be a New Bioelectronics Approach to Crohn’s Disease (embargoed for June 9, 2015)
- Relief of Dystonia Symptoms Is Sustained in Pediatric Patients Undergoing Deep Brain Stimulation (embargoed for June 9, 2015)
- World’s First Publicly Funded Spinal Cord Stimulation Pilot Study Supports Feasibility of a Full Clinical Trial in Refractory Angina Pectoris
(embargoed for June 9, 2015)
- Five Scientific Abstracts Win Inaugural Competition at the International Neuromodulation Society 12th World Congress
(embargoed for June 9, 2015)
- Spinal Cord Stimulation for Chronic Pain Led to Decreased Healthcare Costs and Improved Functional Measures (embargoed for June 10, 2015)
- International Neuromodulation Society Names a Giant of Neuromodulation
(embargoed for June 10, 2015)
- International Congress to Highlight Ways Neuromodulation Transforms Medical Treatment
- Neuromodulation Innovation - And Reimbursement
- Experts, Patients Present Neuromodulation Therapies
- Experts Share Advances in Neural Interventions for Chronic Conditions
FREE public lecture "Neurostimulation & patients"
Moderator: journalist Bernard Derome
Organized by the Canadian Neuromodulation Society & INS
Saturday, June 6, 2015 from noon - 4:40 p.m.
About the INS World Congress
The INS World Congress draws more than 1,500 clinical, engineering and investment leaders and entrepreneurs from five continents and encompasses the full span of existing and emerging neuromodulation therapies.
When: June 6 - 11, 2015
Where: Fairmont Queen Elizabeth Hotel
900 Rene Levesque Blvd. W
Montreal, Quebec, Canada
H3B 4A5
#INSMontreal
Media Contact
Please email for interviews or onsite press credentials:
Nancy Garcia
Website and Public Education Manager
ngarcia (at) neuromodulation.com
2000 Van Ness Ave.,#414
San Francisco, CA 94109
USA
Office: +1 415 683 3237
Online Newsroom
12th World Congress Scientific Program (preliminary)
Daily session topics include bioelectric medicine (electroceuticals), headache and chronic pain, brain interventions for issues such as Alzheimer’s disease, epilepsy, urogenituary and gastrointestinal issues (including obesity and pelvic motility disorders), heart failure, cancer pain, healthcare access and economics, sensing technologies, neuroimaging and functional investigations.
Specialists in attendance include neurologists, urologists, pain doctors, neurosurgeons, cardiovascular surgeons, gastroenterologists, psychiatrists, physical rehabilitation experts, bioengineers, and scientists such as neurophysiologists and neurochemists.
Did You Know?
". . . Newly developed methods . . . have made it possible to develop new, very powerful therapeutic approaches to serious clinical conditions. Every new branch soon produces its own ramifications and neuromodulation looks like a very fast-growing tree."
- Professor Alim Louis Benabid, MD, PhD, pioneer in developing deep brain stimulation for Parkinson’s disease, Clinatec Institute, LETI-Minatec, CEA Grenoble, Grenoble, France
Neuromodulation improves functioning and reduces suffering through reversible, non-systemic approaches to treatment-resistant conditions that have a neurological basis, such as chronic neuropathic pain or medically refractory epilepsy.
While the devices have received regulatory approval from every major health economy, growing knowledge in neuroscience, microfabrication and translational medicine has led to rapid development of new refinements and emerging indications.
In use for more than 40 years, neuromodulation therapies harness the body's own neural circuitry and deliver a stimulus to discrete locations in the nervous system, often through small implanted electrical-stimulation or drug-delivery devices. Neuromodulation therapies build upon technologies for cochlear implants and cardiac pacemakers, and include spinal cord stimulation for persistent pain, deep brain stimulation for movement disorder, or sacral neurostimulation for bladder or bowel disorders.
|
